BLPH News and Press, Bellerophon Therapeutics Inc. From 04/06/20

WARREN, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the fourth quar...

ION Geophysical (NYSE: IO ) +120%  on expecting big jump in Q1 revenues. More news on: ION Geophysical Corporation, Neptune Wellness Solutions Inc., Cellect Biotechnology Ltd., Stocks on the move, , Read more ...

WARREN, N.J., April 01, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, closed its previously announced registered direct offering of 1,275,000 shares of its common...

WARREN, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, announced that it will host an investor conference call and webcast on the INOpulse ® ...

WARREN, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it has entered into definitive agreements with several healthcare-focus...

Plus Therapeutics. (NASDAQ: PSTV ) +63%   in-licenses novel oncology candidates. More news on: Plus Therapeutics, Inc., Bellerophon Therapeutics, Inc., Owens & Minor, Inc., Stocks on the move, , Read more ...

WARREN, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that expanded access treatment with the INOpulse® inhaled nitric oxide...

Gainers:  ThermoGenesis (NASDAQ: THMO ) +164% . More news on: ThermoGenesis Holdings, Inc., U.S. Gold Corp., Sientra, Inc., Stocks on the move, , Read more ...

Bristol-Myers Squibb Faces Setback in Plavix Litigation Bristol-Myers Squibb (BMY) reported that a Hawaii district court has dismissed its countersuit against the State of Hawaii. The company is currently in an altercation with the state with regard to Plavix drug and its marketing. The Pl...

Gainers: Jiayin Group (NASDAQ: JFIN ) +182% . More news on: Jiayin Group Inc., Hoth Therapeutics, Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...